In a rebuttal to the National Institutes of Health’s claims on its COVID-19 patents, Moderna said company scientists exclusively selected its RNA sequence. Also, the company said the sequence was selected with Moderna technology and without the input of NIH scientists.

A consumer rights advocacy group is crying foul over Moderna’s omission of government scientists in some credits for the company’s Covid-19 vaccine patent application. Moderna and scientists from the National Institutes of Health (NIH) worked together to develop the company’s mRNA vaccine against SARS-CoV-2. 

Vaccines for kids between the ages of 5 and 11 will likely be available in the first half of November, top U.S. infectious disease expert Anthony Fauci said on Oct. 24, predicting a timetable that could see many kids getting fully vaccinated before the end of 2021.

Americans can choose a Covid-19 booster shot that is different from their original inoculation but the recommendation is to stick with the vaccine they got first if available, White House chief medical adviser Dr. Anthony Fauci said on Oct. 22.

People who got Johnson & Johnson’s Covid-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer/BioNTech or Moderna, a study run by the National Institutes of Health showed on Oct. 13.

People who received Johnson & Johnson’s Covid-19 vaccine will have a stronger neutralizing antibody response if they get an mRNA shot as the second dose, Axios reported on Oct. 12, citing a person who has seen data collected by the U.S. National Institutes of Health (NIH).

The National Institutes of Health (NIH) reports that a common and potent diuretic might hold the key to lowering the prevalence of Alzheimer’s disease, particularly in people who are genetically predisposed to the illness. 

In October 2020, the government recommended against kids going trick-or-treating for Halloween out of fear of Covid-19 spread. For Halloween 2021, kids have been given the green light to knock on doors.

Acting U.S. Food and Drug Administration Commissioner Janet Woodcock’s days as interim head of the regulatory agency are numbered due to federal regulations. Not only does President Biden have to appoint a new FDA commissioner, he will also need to tap a new head of the National Institutes of Health (NIH) following the retirement announcement of longtime director Francis S. Collins, M.D., Ph.D.

After serving three presidential administrations, Dr. Francis S. Collins is stepping down as director of the National Institutes of Health at the end of 2021 with a successor yet to be named.